Search - tctmd.com

Displaying 761 - 780 of 1798

Sort: Relevancy | Date

Presentation TCT 2019

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Presenter: Hirotoshi Watanabe

September 28, 2019

Presentation TCT 2019

Aspirin Variability, Interactions and Impact of Different Formulations

Presenter: Dominick Angiolillo

September 28, 2019

Presentation TCT 2019

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Presenter: Sanjit Jolly

September 28, 2019

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

Presenter: Francesco Franchi

September 27, 2019

Presentation TCT 2019

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

Presenter: Carlo Di Mario

September 27, 2019

Presentation TCT 2019

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Presenter: Yoshinobu Onuma

September 27, 2019

Presentation TCT 2019

LM PCI: One Year of DAPT Is Enough, and Sometimes Even Less Is More!

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

LM PCI: The Default Is Prolonged DAPT (>1 year)!

Presenter: Robert Yeh

September 27, 2019

Presentation TCT 2019

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

New Insights on Orbital Technology

Presenter: Jeffrey Chambers

September 27, 2019

Presentation TCT 2019

Taking Control: Treatment Planning in Complex PCI

Presenter: Sandeep Nathan

September 27, 2019

Presentation TCT 2019

Japan's Interventional Practice: Japan's Experience With Imaging in the Complex PCI Patient Population

Presenter: takashi ashikaga

September 27, 2019

Presentation TCT 2019

The Changing Interventional Practice: Managing a Complex PCI Patient Population

Presenter: Richard Shlofmitz

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

Case 2: How Microcirculatory Function Testing Changed My Management in a Patient Without Significant CAD

Presenter: Bruce Samuels

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Presenter: Ajay Kirtane

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Advertisement

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Aspirin Variability, Interactions and Impact of Different Formulations

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

LM PCI: One Year of DAPT Is Enough, and Sometimes Even Less Is More!

LM PCI: The Default Is Prolonged DAPT (>1 year)!

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

New Insights on Orbital Technology

Taking Control: Treatment Planning in Complex PCI

Japan's Interventional Practice: Japan's Experience With Imaging in the Complex PCI Patient Population

The Changing Interventional Practice: Managing a Complex PCI Patient Population

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Case 2: How Microcirculatory Function Testing Changed My Management in a Patient Without Significant CAD

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content